The benefits of excess EPCR.
Raife
T J
TJ
Department of Pathology, The University of Iowa, Iowa City, IA 52242, USA.
Lentz
S R
SR
D000818:Animals; D001779:Blood Coagulation Factors / Q000096:biosynthesis* / Q000502:physiology*; D004195:Disease Models, Animal; D004730:Endothelium, Vascular / Q000166:cytology; D006470:Hemorrhage; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic; D008954:Models, Biological; D011486:Protein C / Q000378:metabolism; D018046:Protein C Inhibitor / Q000378:metabolism; D011956:Receptors, Cell Surface / Q000096:biosynthesis* / Q000502:physiology*; D011994:Recombinant Proteins / Q000737:chemistry; D018805:Sepsis; D013997:Time Factors; D015854:Up-Regulation
D001779:Blood Coagulation Factors; D011486:Protein C; D018046:Protein C Inhibitor; D011956:Receptors, Cell Surface; D011994:Recombinant Proteins; C091963:activated protein C receptor